The hepatitis B virus is responsible for most of the chronic liver disease and liver cancer worldwide. As actual therapeutic strategies have had little success in eradicating the virus from hepatocytes, and as lifelong treatment is often required, new drugs targeting the various phases of the hepatitis B virus (HBV) lifecycle are currently under investigation. In this review, we provide an overview of potential future treatments for HBV.
Bartoli, A., Gabrielli, F., Tassi, A., Cursaro, C., Pinelli, A., Andreone, P. (2021). Treatments for HBV: A Glimpse into the Future. VIRUSES, 13(9), 1-30 [10.3390/v13091767].
Treatments for HBV: A Glimpse into the Future
Gabrielli, FilippoWriting – Original Draft Preparation
;Cursaro, CarmelaSupervision
;Andreone, PietroSupervision
2021
Abstract
The hepatitis B virus is responsible for most of the chronic liver disease and liver cancer worldwide. As actual therapeutic strategies have had little success in eradicating the virus from hepatocytes, and as lifelong treatment is often required, new drugs targeting the various phases of the hepatitis B virus (HBV) lifecycle are currently under investigation. In this review, we provide an overview of potential future treatments for HBV.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
